Thrombasthenic mice generated by replacement of the integrin α(IIb) gene: Demonstration that transcriptional activation of this megakaryocytic locus precedes lineage commitment

Blood

Volumn 96, Issue 4, 2000, Pages 1399-1408

  Tronik Le Roux, D ^a   Roullot, V ^a   Poujol, C ^a   Kortulewski, T ^a   Nurden, P ^a   Marguerie, G ^a  

^a DIF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; GANCICLOVIR; INTEGRIN; THYMIDINE KINASE;

ADOLESCENT; AGED; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL MATURATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; GENE ACTIVATION; GENE INSERTION; GENETIC RECOMBINATION; GENETIC TRANSCRIPTION; GLANZMANN DISEASE; HEMATOPOIETIC STEM CELL; KNOCKOUT GENE; MEGAKARYOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE;

EID: 0034663430     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.4.1399     Document Type: Article

References (60)

1. Regulation of megakaryopoiesis
2. Thrombopoietin: The primary regulator of platelet production
3. The regulation of megakaryocytopoiesis
4. Targeting of an inducible toxic phenotype in animal cells
5. Thymidine kinase obliteration: Creation of transgenic mice with controlled immune deficiency
6. Thy-1 tk transgenic mice with a conditional lymphocyte deficiency
7. The relationship of IL-4 and IFNγ-producing T cells studied by lineage ablation of IL-4 producing cells
8. Conditional ablation of dentritic cells in transgenic mice
9. Suppression of erythro-megakaryocytopoiesis and the induction of reversible thrombocytopenia in mice transgenic for the thymidine kinase gene targeted by the platelet glycoprotein α(IIb) promoter
10. GPIIb-IIIa: The responsive integrin
11. 3 export to the platelet surface
12. Glanzmann's thrombasthenia: The spectrum of clinical disease
13. A 2.7-kb portion of the 5'-flanking region of the murine glycoprotein α(IIb) is transcriptionally active in primitive hematopoietic progenitor cells
14. PCR cloning and sequence of the murine GPIIb gene promoter
15. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
16. Derivation of completey cell culture-derived mice from early-passage embryonic stem cells
17. Production of targeted embryonic stem cell clones
18. Production of completely ES cell derived fetuses
19. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene
20. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR
21. Conditions controlling the proliferation of hematopoietic stem cells in vitro
22. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice
23. Human platelets possess an inducible and saturable receptor specific for fibrinogen
24. Ultra-structural analysis of bone marrow hematopoiesis in mice transgenic for the thymidine kinase gene driven by the α(IIb) promoter
25. Pluripotential stem cell lines as a route into the mouse germ line
26. Production of chimeras and genetically defined offspring from targeted ES cells
27. The herpes simplex virus type 1 thymidine kinase is expressed in the testes of transgenic mice under the control of a cryptic promoter
28. A truncated herpes simplex thymidine kinase phosphorylates thymidine and nucleoside analogs and does not cause sterility in transgenic mice
29. The follicle-stimulating hormone (FSH) β- and common α-subunits are expressed in mouse testis, as determined in wild type mice and those transgenic for the β-subunit/herpes simplex virus thymidine kihase fusion gene
30. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1
31. Development of haematopoietic cells lacking transcription factor GATA1
32. An early hematopoietic defect in mice lacking the transcription factor GATA-2
33. Tumor chemosensitivity conferred by inserted thymidine kinase genes: Paradigm for a prospective cancer control strategy
34. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
35. An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse
36. Characterization and purification of a primitive hematopoietic cell type in adult mouse marrow capable of lymphomyeloid differentiation in long-term marrow switch cultures
37. Erythropoietic repopulating ability of stem cells from long- term marrow culture
38. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers
39. Retrovirus-mediated gene transfer to purified hemopoietic stem cells with long-term lympho-myelopoietic repopulating ability
40. Multilineage gene expression precedes commitment in the hematopoietic system
41. Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7
42. Wavering on commitment
43. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5
44. Cell-lineage antigens of the stem cell-megakaryocyte-platelet lineage are associated with the platelet IIb-IIIa glycoprotein complex
45. Expression of antigens of the platelet glycoprotein IIb-IIIa complex on human hematopoietic stem cells
46. Glycoprotein IIb-IIIa is expressed on avian multi-lineage hematopoietic progenitor cells
47. Integrin trafficking regulates adhesion to fibronectin during differentiation of mouse peri-implantation blastocysts
48. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival
49. 3
50. A mouse model of severe von Willebrand disease: Defects in hemostasis and thrombosis
51. Lymphocyte suppressive peptides from fibrinogen are derived predominantly from the Aα chain
52. Fibrin(ogen) mediates acute inflammation responses to biomaterials
53. Regulation of leukocyte-endothelial interaction and leukocyte trans-endothelial migration by intercellular adhesion molecule I-fibrinogen recognition
54. Megakaryocytes from the bone marrow of a patient with Glanzmann's thrombasthenia lacked GP IIb-IIIa complexes
55. Uptake of plasma fibrinogen into the alpha granules of human megakaryocytes and platelets
56. 3 (glycoprotein IIb-IIIa)
57. Platelet GPIIb/IIIa antagonists: The first anti-integrin receptor therapeutics
58. Severe hypercholesterolemia and atherosclerosis in Apolipoprotein E-deficient mice created by homologous recombination in ES cell
59. Atherosclerosis in transgenic mice overexpressing Apolipoprotein A-II
60. Mouse model of arterial injury